zoledronic acid has been researched along with Lymphoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalla-Pozza, L; Little, DG; Munns, CF; Padhye, B | 1 |
Sayin, M; Yazici, G | 1 |
Cataldo, VD; Dong, W; Fanale, MA; Fayad, LE; Fowler, N; Hagemeister, FB; Jimenez, C; Kwak, LW; McLaughlin, P; Murphy, WA; Neelapu, S; Pro, B; Romaguera, J; Samaniego, F; Sanjorjo, P; Shah, J; Thompson, MA; Toth, B; Westin, JR | 1 |
Idrees, AS; Inoue, C; Minato, N; Morita, CT; Murata-Hirai, K; Okamura, H; Sugie, T; Tanaka, Y; Toi, M | 1 |
1 trial(s) available for zoledronic acid and Lymphoma
Article | Year |
---|---|
Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Female; Humans; Imidazoles; Lymphoma; Male; Middle Aged; Neoplasm Staging; Treatment Outcome; Young Adult; Zoledronic Acid | 2013 |
3 other study(ies) available for zoledronic acid and Lymphoma
Article | Year |
---|---|
Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis.
Topics: Adolescent; Arthralgia; Arthroplasty; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Female; Humans; Imidazoles; Lymphoma; Male; Osteonecrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiography; Retrospective Studies; Time Factors; Zoledronic Acid | 2013 |
Hyperparathyroidism secondary to zoledronic acid infusion: case report.
Topics: Bone Density Conservation Agents; Diphosphonates; Female; Humans; Hyperparathyroidism; Imidazoles; Lymphoma; Middle Aged; Stomach Neoplasms; Zoledronic Acid | 2009 |
Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.
Topics: Cell Line, Tumor; Cytotoxicity, Immunologic; Diphosphonates; Geranyltranstransferase; Hemiterpenes; HL-60 Cells; Humans; Imidazoles; K562 Cells; Leukemia, Myeloid; Lymphoma; MCF-7 Cells; Organophosphorus Compounds; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Tumor Necrosis Factor-alpha; U937 Cells; Zoledronic Acid | 2013 |